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ABSTRACT 
Background: In resource-poor settings, otorrhea causes a significant burden of disease in 
children. Etiologic studies and structured data on otorrhea and chronic otitis media among 
African children remain scarce.  
Methods: Here, we reviewed 678 bacteriologically analyzed otorrhea samples from Luanda 
Children’s Hospital from children ≤15 years of age bet een 2008 and 2015. We then compared 
these to data from other studies among African children through a  literature review of 20 papers 
published over two decades. 
Results: Overall, 32 different bacteria were identified among 542 isolates from 654 children in 
Luanda. Gram-negative bacteria constituted the majority of all isolates (85%), whereby 
Pseudomonas sp was the most common (n = 158, 29%), followed by Proteus sp (n = 134, 25%). 
Among Staphylococcus aureus (n = 106, 10%), 69% of tested isolates were MRSA, and among 
Enterobacteriaceae 14% were ESBL isolates. Resistance to quinolones was rare. Furthermore, in 
a review of the literature, we found a high occurrence of otorrhea and chronic suppurative otitis 
media (CSOM) in children as well as possible gaps in existing knowledge. 
Conclusions: In Angola, Gram-negative rods emerged as common causative agents of otorrhea 
in children followed by S. aureus. The magnitude of chronic otorrhea in Africa represents a 
cause for public health concern.  
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INTRODUCTION 
Globally, ear infections commonly occur, whereby a child with otorrhea in Africa and in other 
resource-poor settings represents an everyday observation. An acutely draining middle ear may 
advance to chronic otorrhea, found in up to 6.6% of school children in Africa. (1) This 
prevalence exceeds the limit set by the World Health Organization (WHO), representing a 
massive public health concern. (2) While otitis media (OM) is generally well-characterized, data 
among African children remain scant. Only a few studies examined the youngest children, while 
studies of chronic suppurative otitis media (CSOM) in tertiary hospitals include patients across 
age groups, not simply children, who are most prone to ear infections. Limited recent data from 
Angola exist. (3, 4)  
Because otorrhea is often neglected or deemed a minor problem, treatment is frequently 
delayed. Poverty, an important underlying factor, affects CSOM in multiple ways, including 
decreased host immunity and exposure to pathological organisms. In addition, parents’ 
knowledge of ear infections, their health-seeking practices and the availability and quality of 
health services all link to poverty. (5) When otorrhea persists, complications such as hearing loss 
as well as extra- and intracranial complications can follow. (2) In Africa, CSOM stands as a 
major cause of preventable hearing loss and a typical mediator in OM-related mortality. (2, 6, 7)  
In industrialized countries, Streptococcus pneumoniae, Haemophilus influenzae and 
Moraxella catarrhalis stand as the major pathogens linked to acute middle-ear infections. 
However, if infection persists and develops into CSOM, the etiology shifts towards a higher 
prevalence of Gram-negative strains. In general, few differences distinguish the etiologies when 
comparing developing and developed countries. (5) However, population and geographic-related 
variety appears to play a role in the etiology of otitis media. (8) For example, in Africa, M. 
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catarrhalis rarely causes AOM, whereas Staphylococcus aureus is common in both acute (9) and 
chronic (10) middle-ear infections. Bacteriological and susceptibility studies, particularly for 
middle-ear infections, are much needed in many countries, including low- and middle-income 
economies, given the risk for uncontrolled or inadequate antibiotic consumption.  (11)  
We, therefore, investigated the cause of ear discharge among young children treated in 
Luanda Hospital, a region with one of the highest incidences of AOM and CSOM in Africa. (7) 
We sought to identify the etiologic agents, changes among those agents over time and the 
associated antibiotic susceptibility patterns. To do so, we conducted a descriptive and 
retrospective laboratory-based study on draining ears in Luanda Children’s Hospital, Angola, 
between 2008 and 2015. We also conducted a literature review on otorrhea and CSOM in 
children in Africa to situate our findings with current knowledge of the burden and etiology of 
these diseases among children across the continent.   
MATERIALS AND METHODS 
Data collection and analysis 
Luanda Children’s Hospital, a public and tertiary referral center, provides treatment to children 
≤15 years of age primarily  ithout referrals from the Angolan capital region. The population of 
Luanda is 2.8 million, an estimated 47% of whom are children <15 years.  (12) Approximately 
300 children are seen daily in the emergency department. With only a single public ear, nose and 
throat unit in Luanda, the majority of children experiencing ear problems are examined and 
treated at the children’s hospital.  ympanocenteses are not performed routinely, although 
samples are taken from draining ears and analyzed by the hospital’s microbiology laboratory 
(established in 2002). AOM is treated with amoxicillin with or without clavulanic acid or 
trimethoprim-sulfa. Otorrhea and CSOM are treated with available topical antimicrobials, 
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typically chloramphenicol, gentamycin, and —despite the expense and inconsistent 
availability—quinolones.  
After receiving ethical approval from the hospital for our study, we collected otorrhea 
data from children ≤15 years bet een 2008 and 2015, including both inpatients and outpatients. 
Laboratory technicians took samples with a sterile swab after cleaning the ear canal with 60% 
alcohol. Ear pus was immediately inoculated on blood and chocolate agar plates and incubated in 
a 3%–4% CO2 atmosphere for 24–48 hours. Bacteria were identified from positive cultures based 
on their colonial features, Gram-staining and standard phenotypic bacteriological methods.  (13) 
Antimicrobial susceptibility was tested using available discs applying CLSI standards (14) and 
the inhibition zones were compared to those from control organisms. The laboratory request 
forms reported the susceptibility of each organism as sensitive, intermediate or resistant.  
In this sample,  e could not track the children’s demographic characteristics given the 
lack of computerized information management systems in Angola. (15) However, previously 
(2004–2005, n = 375) laboratory data on ear pus samples provided estimates for a more specific 
age range. Data were analyzed using SPSS.   
Literature review 
Through a literature review, we aimed to answer two structured questions: First, what is the 
prevalence of OM in African children ≤15 years  hen CSOM and otorrhea are accepted? 
Second, what are the causative agents in these patients?  We conducted a search (see 
Supplemental Digital 1, http://links.lww.com/INF/D376 for the specific search terms) of the 
Medline, African Journals OnLine, African Index Medicus and Cochrane databases for articles 
published between January 1997 and June 2017. Additionally, we manually searched citations in 
published papers and reviews. Figure 1 illustrates the study screening and selection processes. 
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The predefined protocol outlined the inclusion of studies describing the prevalence or etiologic 
agents or both in pediatric CSOM or otorrhea among at least 30 patients regardless of language 
of publication. Studies with a wider age range of participants were included if the results were 
reported separately for children ≤15 years of age. In addition,  e revie ed and included 
publications assessing the burden of pediatric OM if the burden of disease was analyzed against 
children in the health-care setting. 
RESULTS 
Luanda Children’s Hospital 
In total, 678 samples were obtained from 654 children, of whom 296 (44%) were girls. In earlier 
years’ ear pus samples (n = 375), children ranged in age from 2 weeks to 13 years, with the 5–
95% age distribution ranging from 5 months to 7 years. The median age across all children 
reached 2 years. In our sample, bacteria were detected in 542 (80%) specimens, and the 
predominant isolate was registered. No growth was detected in 72 (11%) specimens, while 63 
(9%) specimens were interpreted as contaminated and yielded no results. One sample was 
damaged.  
In total, 542 isolates were identified representing 32 bacterial species (Table, 
Supplemental Digital Content 2, http://links.lww.com/INF/D377). Pseudomonas sp was the most 
common isolate (n = 158, 29%) followed by Proteus sp (n = 134, 25%), S. aureus (n = 106, 
10%), Klebsiella sp (n = 36, 7%), Escherichia coli (n = 34, 6%), Citrobacter sp (n = 24, 4%) and 
S. pneumoniae (n = 21, 4%). The proportional detection rates of these and other etiologies 
remained relatively stable over time (Fig., Supplemental Digital Content 3, 
http://links.lww.com/INF/D378). Gram-negative bacteria constituted the majority of all isolates 
(85%), more specifically primarily comprising enteric rods (52%). Other pathogenic bacteria 
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were also found. Salmonella sp was detected in 14 children, Shigella in 7 children and Yersinia 
sp and zoonotic Edwardsiella tarda in 4 and 3 discharging ears, respectively. Klebsiella ozaenae, 
the causative organism of chronic nasal infections, was identified in 3 samples.  
Antimicrobial susceptibility to at least three antibiotics was conducted for nearly all 
isolates (n = 536, 99%). Ciprofloxacin-resistant Pseudomonas sp remained rare, occurring in 
only 1% of strains. As expected,
 
Proteus mirabilis was typically resistant to chloramphenicol in 
78% of cases, whereas only 7% of strains showed resistance to ciprofloxacin. Among all 
Enterobacteriaceae, 14% were resistant to third-generation cephalosporins (ceftriaxone or 
cefotaxime) and were identified as expanded-spectrum β-lactamase (ESBL)–producing isolates, 
with the highest percentage for E. coli, 47% (7/15). Among S. aureus, 69% (18/26) were MRSA. 
S. aureus was resistant to chloramphenicol in 29% of samples and to ciprofloxacin in 4% of 
samples. Among the S. pneumoniae strains tested, 82% were sensitive to penicillin, while 93% 
were resistant to chloramphenicol. Table 1 summarizes the susceptibility results.  
Literature review 
Our literature search yielded 160 citations, of which we included 20 in our review (Figure 1). 
Among these, 12 publications provided data on the prevalence and the burden of disease, (1, 4, 
16-25) while 8 publications included microbiological data.(26-33) Most studies consisted of 
hospital-based samples, whereas few population-based studies existed. Table 2 presents the 
findings for the prevalence, while Table 3 summarizes the etiological findings of otorrhea and 
CSOM among African children. 
Prevalence and burden of otorrhea and CSOM  
We found three large school-based studies (n = 969–13,109)  (1, 17, 18) and one household 
survey (16) screening ears among unselected populations. In Nigeria, the prevalence of CSOM 
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ranged from 0% in an urban upper-class school to 6% among pupils in rural areas. (1) A 
household survey from the same country reported a 3% prevalence for CSOM. (16) In Kenya, 
CSOM occurred in 1.5% of children, typically in children under 6 years old and later in children 
13–15 years old.  (18)  
Among HIV-positive children, otorrhea was common, occurring in up to 32% of patients.  
(19) Few papers examined otorrhea and CSOM in primary care settings, where CSOM affected 
up to 7% of attending children. Two studies from tertiary ENT units in Nigeria took a closer look 
at the burden of pediatric OM, accounting for 45% of all new ENT cases and 5% of all visits. 
(24, 25)  
Etiology of otorrhea and CSOM 
Only 8 studies met our inclusion criteria for etiological reporting (Table 3). The most common 
causative agents in otorrhea consisted of Pseudomonas sp (19–57%), Proteus sp (11–47%), S. 
aureus (5–40%) and E. coli (3–17%). By contrast, for CSOM, the causative agents included 
Proteus sp (22–43%), Staphylococcus sp (37%), Pseudomonas sp (13–15%) and S. aureus (5–
14%). Only one laboratory performed fungal analysis (28), two anaerobic analysis  (32, 33) and 
one mycobacterial cultures. (32) The antimicrobial susceptibility to fluoroquinolones was widely 
favorable for Gram-negative bacteria.  (29, 32, 33) 
DISCUSSION 
Ear drainage among children in developing countries often yields Gram-negative rods. The most 
common Gram-positive organism found in Luanda was S. aureus, with S. pneumoniae and H. 
influenzae detected rather rarely. Thus, in our sample, Angolan children most likely suffered 
from chronic or recurrent discharge. Unexpectedly, Salmonella sp, Yersinia sp and Edwardsiella, 
were observed, findings not previously reported to the best of our knowledge. Our group, 
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however, previously identified a case of Shigella from ear discharge in the same laboratory in 
Luanda. (3) We assume that contaminated water, close contact between humans and animal feces 
and perhaps some traditional treatment practices (34) explain the variety of Gram-negative 
bacteria in our sample.  
Furthermore, the pathogen spectrum in our cohort agrees with several other studies 
among African children (Table 3). In those studies, Pseudomonas and Proteus sp represented the 
most common isolates in otorrhea. Proteus, however, emerged as the most common isolate in 
Ethiopia, Zambia and in one study from South Africa.  (26, 27, 32, 33) In our study, we found S. 
aureus in one-tenth of the isolates, typically detected in 5%–40% of otorrhea cases. (28, 29) 
While previous studies took into account a child’s HIV status and sickle cell disease, no 
differences were found between the agents in HIV-positive and HIV-negative children.  (4, 32) 
However, immunosuppression may still be an important factor as, for example, Tiedt et al. 
detected Proteus mirabilis more frequently among underweight children. (32)  
Topical ciprofloxacin emerged as suitable treatment alternative for discharging ears, in 
agreement with current WHO guidelines for CSOM, since at least 93% of the four most common 
isolates were susceptible to it. While only half of the studies reviewed provided relevant 
information on antimicrobial resistance in children, susceptibility to quinolones remained high: 
for instance, 80% of all isolates in Zambia and 95% of Gram-negative and 93% of Gram-positive 
bacteria in South Africa. (9, 32) However, in Nigeria, the overall susceptibility rates were 
somewhat lower for quinolones. (28, 29)  
MRSA commonly occurred in our series. In one study from South Africa, (9) no MRSA 
was detected from ear discharge, while other studies did not report its prevalence among 
children. Turning to ESBL, the 14% prevalence ESBL-producing Enterobachteriaceae reported 
CC
EP
TE
D
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
11 
 
here agrees with rates of 23% for ESBL observed elsewhere in Africa. (35) Since susceptibility 
to carbapenems was not examined, we have no information regarding the potential 
carbapenemase-producing Enterobacteriaceae strains. 
Our literature review identified only a few studies from Africa focusing or reporting 
specifically on children. In particular, children under the age of 5 remained underrepresented in 
population-based studies, and only a few studies were conducted in primary health care settings. 
In general, the role of poverty was clearly linked to CSOM since it significantly associated with 
a child’s lo  socio-demographic status and their parent’s education. (17) Similarly, persistent 
otorrhea associated with rural residency in one study (1) although such a clear difference was not 
observed in Kenya.  (18) Since our review of the literature, two cross-sectional studies among 
children have appeared, providing estimates for otorrhea and CSOM. In rural Malawi among 
children 4–6 years old (n = 281), 5.4% suffered from CSOM. (36) In Rwanda among children 
under 5 (n = 810), middle-ear infections occurred in 5.8% of children with 2% showing signs of 
active otorrhea.  (37) These studies underline the need for public health interventions. 
While this study offers a clearer picture of CSOM in African children, we acknowledge 
several limitations to our study. Primarily, economic constraints presented one major obstacle to 
a more thorough study. An inadequate patient database from the hospital prevented a more 
detailed collection of patient data (including possible comorbidities), and we were unable to 
confirm the origin of otorrhea. In some cases, external otitis might have been included in our 
patient series. The age range from previous years likely matches our sample, since we expect no 
dramatic changes have occurred in the patient distribution during the period during which our 
sample was collected.  
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In addition, the Luanda microbiology laboratory lacked the facilities necessary for 
anaerobic, viral and fungal diagnostics. Furthermore, we could not culture mycobacteria, which 
also cause ear infections in Africa. Evidently, the role of mycobacteria appears minor, since we 
identified only one study with a single case of otogenic tuberculosis.  (32) Still, we argue that the 
role of mycobacteria is underestimated in Africa since it is surging in areas with a high 
tubercular endemicity. (38)  We also argue that the number of mixed infections in this study was 
likely underestimated. The number of otorrhea samples fluctuated greatly over time (Figure, 
Supplemental Digital Content 3, http://links.lww.com/INF/D378) likely stemming from periodic 
lack of resources—a rather common occurrence in Africa.  
We limited our literature review to a few databases and only assessed data descriptively. 
However, to our knowledge, no previous review focused solely on African children. A review by 
DeAntonio et al. presented the epidemiology of OM in developing countries among children <5 
years old, highlighting the global burden and prevalence of OM. (39) Their study included 15 
African publications published between 1992 and 2011, which were primarily hospital rather 
than population based. That study showed a peak prevalence of OM among the youngest 
children.  
Similar to the etiologies reported in other studies, our study indicates that Gram-negative 
rods are commonly present in otorrhea in Angola, whereas S. aureus remains the most common 
Gram-positive agent with a 69% representation of MRSA. Resistance to quinolones remains rare. 
Among all Enterobacteriaceae, 14% consisted of ESBL. Our literature review identified a 
limited number of studies focusing on the youngest children providing current estimates for 
CSOM. The prevalence of persistent otorrhea across studies seems sufficiently high to cause 
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concern among public health professionals. Thus, much greater attention should be paid to this 
mostly neglected child health issue. 
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Figure 1. Flowchart of literature review from database and manual searches 
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Table 1. Sensitivity of tested bacterial isolates* from ear pus samples from children in Luanda, Angola  
 
Penicillin Amoxicillin Chloramphenicol Ciprofloxacin 
Third-
generation 
cephalosporin† 
Ceftazidime Gentamicin TMP/SMX‡ 
Staphylococcus aureus 12/33 (36%)  24/34 (71%) 28/30 (93%)   12/18 (67%) 12/14 (86%) 
Streptococcus pneumoniae 9/11 (82%)  13/14 (93%) 2/2 (100%) 6/7 (86%)   1/4 (25%) 
Haemophilus influenzae  2/4 (50%) 0/4 (0%)  4/4 (100%)   0/3 (0%) 
Pseudomonas sp    91/92 (99%) 43/54 (80%) 81/84 (96%) 69/91 (76%))  
Proteus mirabilis  17/44 (39%) 15/67 (22%) 55/59 (93%) 40/41 (98%) 0/36 (0%) 51/64 (80%) 17/59 (29%) 
Klebsiella sp  2/8 (25%) 10/21 (48%) 26/28 (93%) 10/13 (77%) 10/13 (77%) 19/22 (86%) 9/23 (39%) 
Escherichia coli  3/15 (20%) 3/16 (19%) 18/22 (82%) 8/15 (53%) 15/17 (88%) 14/23 (61%) 7/24 (29%) 
All Enterobacteriaceae   47/162 (29%) 156/169 (92%) 95/110 (86%)    
*Isolates may have been tested for sensitivity to different antimicrobial agents. 
†Ceftriaxone or cefotaxime 
‡Trimethoprim-sulfamethoxazole 
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Table 2.  Prevalence of otorrhea and CSOM among children aged ≤15 years in Africa among unselected and selected populations 
Country, year, reference Study setting, design Age range Diagnosis Prevalence: n diagnosis /  
n children (%) 
 Unselected population    
Nigeria, 2003 (1) School, cross-sectional 8–15 years CSOM Rural 42/699 (6); urban 0/270 (0) 
Nigeria, 2005  (16) Household survey, cross-sectional 0–12 years CSOM 15/600 (3) 
Nigeria, 2008  (17) School, cross-sectional 9–15 years CSOM 35/1500 (2) 
Kenya, 2015  (18) School, cross-sectional 2–15 years CSOM 203/13,109 (2) 
 Selected population    
South Africa, 2007  (19) HIV, primary care clinic, retrospective  7–45 months Otorrhea 104/326 (32) 
Nigeria, 2007  (20) HIV, hospital, case-control 7 months–11 
years 
Otorrhea 28/258 (11) 
Angola, 2011 (4) HIV, hospital, case-control 9 monts–14 
years 
CSOM 
Dry perforation 
HIV 21/78 (27); controls 3/78 (4) 
HIV 7/78 (9); controls 1/78 (1) 
Angola, 2012  (21) SCD*, hospital, case-control 8 months–15 CSOM Controls 2/61 (3) 
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years Dry perforation SCD 1/61 (2) 
South Africa, 2014  (22) Primary care clinic, cross-sectional 2–15 years CSOM 8/121 (7) 
South Africa, 2014  (23) Primary care clinic, cross-sectional 2–15 years CSOM 9/180‡ (5) 
*Sickle cell disease 
†Lower respiratory tract infection 
‡Ears 
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Table 3. Etiological studies on otorrhea and CSOM among African children ≤15 years old 
Diagnosis 
Country, year, 
reference 
Study setting, 
design* 
Data 
collection 
Age range 
n isolates / 
n samples /  
n children  
Main pathogens identified n (%) 
Otorrhea Ethiopia, 2009  (26) Laboratory 
Retrospective 
2000–2008 2 months–15 
years 
256/315/315 
Proteus 120/256 (47) 
Staphylococcus aureus 93/256 (36) 
 Ethiopia, 2011  (27) Laboratory 
Retrospective 
2003–2010 2 months–14 
years 
331/354/354 Proteus 103/331 (31) 
S. aureus 75/331 (23) 
Pseudomonas 63/331 (19)  
Escherichia coli 56/331 (17) 
 Nigeria, 2011  (28) Laboratory 
Retrospective 
NA 0–12 years 301/400/NA S. aureus 116/289† (40) 
Proteus mirabilis 82/289 (28) 
E. coli 33/289 (11) 
Streptococcus sp 27/289 (9) 
 Nigeria, 2011  (29) Hospital 
Retrospective 
2006–2007 0–15 years 61/65/65 Pseudomonas 35/61 (57)  
Klebsiella 10/61 (16) 
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Proteus 7/61 (11)   
S. aureus and Streptococcus pyogenes each 3/61 (5)  
 Nigeria, 2012  (30) Laboratory 
Retrospective 
12 months, 2010 0–14 years 59/59/60 Pseudomonas 29/59 (49) 
S. aureus and Proteus each 14/59 (24) 
E. coli 2/59 (3) 
CSOM Ethiopia, 2004  (31) Hospital 
NA 
 
14 months, 2002–
2003 
2 months–15 
years 
99/NA/92 Proteus 43/99 (43)  
S. aureus 14/99 (14)  
Pseudomonas aeruginosa 13/99 (13)  
 South Africa, 2013  
(32) 
Hospital 
Prospective 
 
17 months, 2009–
2010 
1–12 years 153/113/86 Proteus mirabilis 33/153 (22)  
Pseudomonas aeruginosa 22/153 (14) 
Haemophilus influenzae 22/153 (14) 
Providencia and S. aureus each 7/153 (5)  
 Zambia, 2016  (33) Hospital 
Retrospective 
 
2014–2016 0–15 years 60/60/60 Staphylococcus sp 22/60 (37) 
Proteus 21/60 (35) 
Pseudomonas 9/60 (15) 
Streptococcus 4/60 (7) 
*Data collection 
†Etiologies reported among those isolates tested for antimicrobial susceptibility  
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Figure 1 
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Medline        97 
African Journals OnLine     30 
African Index Medicus     21 
Cochrane Library      3 
Manual search of closely related reviews and papers 21 
 
  After removal of duplicates n = 160 
  
SCREENING 
Excluded based on 
title or abstract 
 
n = 79 
ASSESSMENT FOR ELIGIBILITY 
 
No access n = 9 
Full papers screened n = 72 
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- Irrelevant: 23 
- No results in children ≤15: 
23 
- # of patients <30: 3 
- Before inclusion period: 1 
- Same study population: 2 
 
n = 52 
 
 INCLUDED 
Full papers included in the analysis n = 20 
 
 
 
 
 
 
 
 
 
 
To assess etiology 
n = 8 
To assess 
prevalence and 
burden 
n = 12 
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